ASTRAZENECA PLC's ticker is AZN and the CUSIP is 046353108. A total of 1,120 filers reported holding ASTRAZENECA PLC in Q4 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,402,882 | +47.4% | 17,988 | +28.1% | 0.31% | +35.2% |
| Q1 2024 | $951,479 | -8.7% | 14,044 | -9.2% | 0.23% | -18.1% |
| Q4 2023 | $1,042,224 | +1.9% | 15,475 | +2.5% | 0.28% | -35.1% |
| Q3 2023 | $1,022,623 | -5.0% | 15,101 | +0.4% | 0.43% | -9.3% |
| Q2 2023 | $1,076,896 | +2.6% | 15,047 | -0.5% | 0.47% | -4.1% |
| Q1 2023 | $1,049,826 | +12.4% | 15,125 | +9.8% | 0.49% | +2.9% |
| Q4 2022 | $934,284 | -0.6% | 13,780 | -19.6% | 0.48% | -5.4% |
| Q3 2022 | $940,000 | -18.2% | 17,140 | -1.4% | 0.50% | -11.7% |
| Q2 2022 | $1,149,000 | -2.5% | 17,390 | -2.1% | 0.57% | +24.1% |
| Q1 2022 | $1,179,000 | +18.0% | 17,770 | +3.6% | 0.46% | +16.8% |
| Q4 2021 | $999,000 | -2.2% | 17,145 | +0.9% | 0.39% | -4.6% |
| Q3 2021 | $1,021,000 | +0.2% | 17,000 | -0.1% | 0.41% | +2.0% |
| Q2 2021 | $1,019,000 | – | 17,015 | – | 0.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| STARR INTERNATIONAL CO INC | 93,000 | $5,586,000 | 11.21% |
| Eagle Health Investments LP | 449,565 | $27,001,000 | 8.56% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,291,667 | $77,578,000 | 6.52% |
| Healthcare Value Capital, LLC | 50,000 | $3,003,000 | 5.93% |
| ARDSLEY ADVISORY PARTNERS LP | 500,000 | $30,030,000 | 4.58% |
| Asymmetry Capital Management, L.P. | 116,242 | $6,981,000 | 4.20% |
| Swaine & Leidel Wealth Services, LLC | 75,880 | $4,557,000 | 4.02% |
| Sofinnova Investments, Inc. | 1,128,272 | $67,764,000 | 4.01% |
| Eversept Partners, LP | 890,808 | $53,501,928 | 3.71% |
| Ruffer LLP | 1,971,796 | $117,064,000 | 3.70% |